BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 16634896)

  • 1. Connexin 43 in Dermatofibroma and Dermatofibrosarcoma Protuberans: Diagnostic, Pathogenic, and Therapeutic Implications.
    Fernandez-Flores A; Varela-Vazquez A; Mayan MD; Fonseca E
    Am J Dermatopathol; 2023 Dec; 45(12):812-815. PubMed ID: 37982464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of collagen refractility in dermatofibroma and dermatofibrosarcoma protuberans using diffractive microscopy.
    Brailsford C; Khamdan F; Dirr MA; Sagut P; Nietert PJ; Elston D
    J Cutan Pathol; 2024 Apr; 51(4):306-310. PubMed ID: 38124386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing.
    Bandyopadhyay B; Fan J; Guan S; Li Y; Chen M; Woodley DT; Li W
    J Cell Biol; 2006 Mar; 172(7):1093-105. PubMed ID: 16549496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of human adipose tissue-derived stem cells on dermatofibrosarcoma protuberans cells in an indirect co-culture: an in vitro study.
    Yuan Z; Zhu Z; Zhu F; Ding F; Wang Y; Wang X; Luo X; Yang J; Liu F; Sun D
    Stem Cell Res Ther; 2021 Aug; 12(1):440. PubMed ID: 34362454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal regulation of vessel stability by MMP14 and TGFbeta.
    Sounni NE; Dehne K; van Kempen L; Egeblad M; Affara NI; Cuevas I; Wiesen J; Junankar S; Korets L; Lee J; Shen J; Morrison CJ; Overall CM; Krane SM; Werb Z; Boudreau N; Coussens LM
    Dis Model Mech; 2010; 3(5-6):317-32. PubMed ID: 20223936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is telomerase reactivation associated with the down-regulation of TGF beta receptor-II expression in human breast cancer?
    Elkak AE; Newbold RF; Thomas V; Mokbel K
    Cancer Cell Int; 2003 Jul; 3(1):9. PubMed ID: 12877749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putting transcriptional brakes on fibrosis: a negative regulator of TGFβ signaling.
    Rohil A; Talekar S; Shammas KM; Ajay AK
    Trends Cell Biol; 2023 Sep; 33(9):734-735. PubMed ID: 37380582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations.
    Campione E; Di Prete M; Costanza G; Saggini A; Agostinelli S; Terrinoni A; Centofanti F; Rapanotti MC; Bianchi L; Ferlosio A; Scioli MG; Orlandi A
    Dermatopathology (Basel); 2023 Aug; 10(3):231-243. PubMed ID: 37606484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging Patterns of Atypical Dermatofibromas and Promising Diagnostic Tools for Differential Diagnosis of Malignant Lesions.
    Orzan OA; Dorobanțu AM; Gurău CD; Ali S; Mihai MM; Popa LG; Giurcăneanu C; Tudose I; Bălăceanu B
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of leukocyte-specific protein 1-positive cells: a clue to the cell of origin and a marker for the diagnosis of dermatofibroma.
    Jin SY; Choi JS; Choi YL; Choi YL; Kim DH; Lee SH
    Ann Dermatol; 2015 Apr; 27(2):157-62. PubMed ID: 25834354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
    Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
    Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.
    Kubo M; Ihn H; Yamane K; Tamaki K
    J Rheumatol; 2002 Dec; 29(12):2558-64. PubMed ID: 12465152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
    Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
    Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart.
    Mercado-Pimentel ME; Runyan RB
    Cells Tissues Organs; 2007; 185(1-3):146-56. PubMed ID: 17587820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M; Ihn H; Yamane K; Tamaki K
    Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression levels of thrombospondin-1 in dermatofibroma and dermatofibrosarcoma protuberans.
    Maekawa T; Jinnin M; Ohtsuki M; Ihn H
    Eur J Dermatol; 2011; 21(4):534-8. PubMed ID: 21697041
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.